Fufang Ejiao Jiang and Bone Marrow Recovery After Chemotherapy: What Metabolomics Reveals
Researchers explored the mechanisms of action of Fufang Ejiao Jiang in the treatment of chemotherapy-induced myelosuppression, using a metabolomics and network pharmacology approach. The study, led by Mingxin Guo and collaborators, applied liquid chromatography coupled with mass spectrometry (LC-MS) to identify relevant metabolites. The results indicated that Fufang Ejiao Jiang may modulate various metabolic pathways, promoting the recovery of bone marrow cells. This traditional formulation, which combines ingredients such as deer horn collagen, showed potential to improve blood cell counts and reduce the side effects of chemotherapy. However, the study is still preliminary and is based on experimental models, which limits the generalization of the findings to clinical practice.




